Jump to section
To advance healthspan with the next generation of nutrients.
Helaina is a biotechnology company revolutionizing infant nutrition by replicating key breast milk proteins. Using precision fermentation, it produces complex proteins at scale, making them widely accessible.
Helaina's technology produces high-quality, bioequivalent lactoferrin. This lactoferrin is a fully functional protein that significantly enhances the nutritional profile of infant formula. By supporting the immune system and aiding nutrient absorption, this breakthrough may transform infant nutrition.
Helaina's mission goes beyond improving baby formula, with the aim to set a new standard in nutrition across various applications. As the company scales its production, integrating these proteins into diverse food products becomes feasible, promising better nutrition for infants and overall public health improvements.
Kirsty
Company Specialist at Welcome to the Jungle
Sep 2024
$45m
SERIES B
Nov 2021
$20m
SERIES A
This company has top investors
Laura Katz
(CEO)Previously developed food products for NUGGS, Plated and Dylan's Candy Bar. Laura became NYU's youngest-ever adjunct professor in Food Science and Technology in 2017 and was featured in Forbes' 30 under 30 list in 2022.